News

A cross-sectional analysis of a Penn Medicine primary care practice shows which patients may prefer a phone or tablet versus a computer.

The latest indications for the novel selective antibody will make it available as a treatment for pustular psoriasis.

The odds of HBV seroprevalence in participants with no or primary education was higher than individuals with secondary level education or higher.

The 3-D technology was able to produce custom frames with a successful fit for patients with craniofacial anomalies at risk of vision loss.

In the second portion of the Rare Disease Report: CDKL5 podcast, Elia Pestana Knight, MD, a pediatric epileptologist shares her clinical expertise on CDKL5 deficiency disorder (CDD).

A study from Germany elucidated new information on the rare uncombable hair syndrome, changing the ways in which the syndrome may be analyzed.

Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.

A novel biomarker was identified for posterior uveitis that postulates previously undetected sources of green and red emission fluorescent components (GEFC/REFC).

According to new research, stroke occurrence trends coinciding with tuberculous meningitis (TBM) are suggested to have regional characteristics.

Serum total cholesterol, HDL-C, and LDL-C were associated positively with IOP, while triglyceride levels may be associated negatively.

The strongest risk factor for RVO was identified as nonideal blood pressure, followed by nonideal body mass index.

The investigators found no significant differences when trainees participated in the ADR, CIR, and perforation rate compared to when trainees did not participate.

Older participants had smaller dual-task performance deficits for gait and texting speed in both the ADHD group and the control group.

NAFLD patients had a 13% higher risk of developing IBS after multivariable adjustment compared to patients without NAFLD.

The mean daily alcohol consumption was also lower in the psilocybin group compared to the placebo group.

A lower SPPB score was associated with greater risk of composite and individual CVD outcomes.

Olipudase alfa (Xenpozyme) was developed by Sanofi to treat symptoms unrelated to the central nervous system in pediatric and adult patients with the life-threatening condition.

Recent research from George Washington University analyzed the effects of COVID-19 on recruitment and funding for medical school pathway programs.

The FDA granted priority review for the Bioloigics License Application (BLA) Sanofi submitted for efanesoctocog alfa indicated for individuals with hemophilia A with a decision date set for February 28, 2023.

Temperatures changes between summer and the rest of the year correlated with the magnitude of decrease in renal function during summer.

In the first episode of a 2-part Rare Disease Report, Whitney Mitchell, mother and caregiver to her 5 year old daughter Havilah, shared her experience leading up to, and now living with, Havilah’s CDKL5 deficiency disorder diagnosis.

In the study, 60.4% achieved resolution of ascites, encephalopathy, and absence of recurrent variceal bleeding for at least 12 months.

The results show 88.6% of participants had medium to high range emotion exhaustion, while 82.8% exhibited medium to high range depersonalization and 19.6% of patients had low to medium range personal accomplishment.

Increased risk of AF by fish oil supplement was found to be prominent in low­ risk participants with healthy lifestyles.

Patients with Parkinson disease had more pronounced sleep instability than those with other disorders marked by alpha-synuclein buildup, but those differences diminished after adjusting for medication differences, a new study found.

Full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications in critically-ill patients with COVID-19.

An Oakland-based analysis of mortality among homeless adults aged ≥50 years old illuminates the need for more proactive homeless care policies.

Digital screening more than doubled the detection rate of treatment-relevant AF in both phases of eBRAVE-AF trial.

Pemigatinib (Pemazyre) becomes the first and only targeted treatment for adults with extremely rare and aggressive blood cancer.

A recent study developed framework to improve fall prevention methodology across the country’s primary health care system.